BFM
PASG icon

Boothbay Fund Management’s Passage Bio PASG Stock Holding History

Boothbay Fund Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Buy
+18,871
New +$195K ﹤0.01% 1827
2022
Q3 		– Sell
-752
Closed -$35K – 2510
2022
Q2 		$35K Buy
+752
New +$35.1K ﹤0.01% 2121
2021
Q3 		– Sell
-769
Closed -$204K – 2109
2021
Q2 		$204K Hold
769
– – 0.01% 1515
2021
Q1 		$269K Buy
769
+54
+8% +$23.1K 0.01% 1241
2020
Q4 		$365K Buy
+715
New +$286K 0.01% 871

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boothbay Fund Management's PASG Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Passage Bio (PASG) in Q1 2026: 18,871 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #1827 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in PASG as recently as Q2 2022.

Boothbay Fund Management first reported a position in PASG in Q4 2020 and has held it in 5 quarters since. The position peaked at $365K in Q4 2020. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Boothbay Fund Management held 18,871 shares of Passage Bio worth $148K as of Q1 2026.
  • Passage Bio was a new Boothbay Fund Management position in Q1 2026.
  • Passage Bio made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1827 holding.
  • Boothbay Fund Management first reported a position in Passage Bio in Q4 2020 and has held it in 5 quarters since.
  • Boothbay Fund Management's Passage Bio position peaked at $365K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.